Stock Comparison
BIIB vs JNJ
Biogen Inc and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$31.25B
$626.01B
P/E (TTM)
37.5
30.1
Forward P/E
17.3
22.3
Price/Sales
3.1
6.4
Price/Book
1.7
7.4
EV/EBITDA
17.8
19.3
Dividend Yield
—
2.00%
Profitability
Net Margin
8.39%
21.83%
Operating Margin
12.79%
26.87%
Return on Equity
4.58%
25.70%
Return on Assets
5.21%
8.60%
Growth (YoY)
Revenue Growth
3.40%
6.60%
Earnings Growth
-84.80%
-0.90%
Price & Risk
Beta
0.2
0.2
52-Week High
$216.63
$267.34
52-Week Low
$132.22
$170.46
Analyst Target
$235.32
$272.50
Compare BIIB and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.